Our Story

In 1995, they conducted the first successful PCR detection of Mycobacterium tuberculosis in a clinical sample, followed by many other accomplishments.

In 2005, Horvath and Dendis founded a small start-up to meet the needs of laboratories and satisfy higher demand for standardization and simplifying of laboratory workflows. 

As of today, GeneProof with 100 employees distributes a portfolio of 75+ products to 75+ countries. 90 % of production is exported.

In 2022, GeneProof merged with American Laboratory Products Company, Ltd., a specialty in vitro diagnostics company from Salem, NH, USA. The combination creates a global market leader in the diagnostic products market, with broad capabilities spanning novel immunoassay testing kits, real-time PCR testing products, and automated laboratory instrumentation solutions. 

GeneProof, partnered with ALPCO, is now a leading Global Diagnostics Company.